Dr. Jeanha Baek, Ph.D., Head of Preclinical Development

Dr. Baek comes with a strong background in translational medical research with an extensive experience in both in vitro and in vivo analyses. Her research interests has always been related to human diseases and finding novel therapies for the diseases that do not currently have a cure.

After receiving a doctoral degree in pharmacology (University of Otago, New Zealand), Dr. Baek continued her research at Karolinska Institute for many years. First, she worked with Prof. Maria Eriksson as a postdoctoral fellow investigating the effects of Progeria, a genetic condition characterised by accelerated premature aging, on the brain. After that, she then joined Prof. Dag Aarsland research group, and explored the field of Lewy body dementia for the discovery novel drug targets.

In 2017, Dr. Baek dived into Parkinson’s disease research in Prof. Per Svenningsson’s group, then later became an Assistant Professor, where she focused on investigating the involvement of the unfolded protein response in Parkinson’s disease.

Education

2011, PhD in Pharmacology
Department of Pharmacology & Toxicology, University of Otago, New Zealand

2005, BSc. (Honors 1st Class) in Pharmacology
Department of Pharmacology & Toxicology, University of Otago, New Zealand